Uptake of genetic counseling and multi‐gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing

Recontacting patients for multigene panel testing in hereditary cancer: Efficacy and insights

(2019) Lindsey Sawyer et al.   Journal of Genetic Counseling

Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma

(2018) Minerva A. Romero Arenas et al.   ANNALS OF SURGICAL ONCOLOGY

Factors Influencing Clinical Follow-Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing

(2018) Sarah E. Chadwell et al.   Journal of Genetic Counseling

Cancer Genetic Counseling and Testing in an Era of Rapid Change

(2017) Gillian W. Hooker et al.   Journal of Genetic Counseling

Standards for the Reporting of Genetic Counseling Interventions in Research and Other Studies (GCIRS): an NSGC Task Force Report

(2017) Gillian W. Hooker et al.   Journal of Genetic Counseling

Making personalized medicine more affordable

(2015) Naomi Aronson   Annals of the New York Academy of Sciences

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

(2015) Lisa R. Susswein et al.   GENETICS IN MEDICINE

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients

(2015) Stephen E. Lincoln et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Frequency of mutations in individuals with breast cancer referred forBRCA1andBRCA2testing using next-generation sequencing with a 25-gene panel

(2014) Nadine Tung et al.   CANCER

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer

(2014) Kara N. Maxwell et al.   GENETICS IN MEDICINE

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

(2014) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast-Cancer Risk in Families with Mutations in PALB2

(2014) Antonis C. Antoniou et al.   NEW ENGLAND JOURNAL OF MEDICINE

How We Design Feasibility Studies

(2009) Deborah J. Bowen et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Recontacting Patients Who have Tested Negative for BRCA1 and BRCA2 Mutations: How, Who and Why?

(2009) Heather Hampel   Journal of Genetic Counseling